effectively demonstrated, their mechanism of action is still far 3 To whom correspondence should be addressed from clear. Their primary cellular target has been assumed to Email: brigitte.marian@univie.ac.at be the inducible cyclooxygenase isoenzyme COX-2 (1). This Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit isoenzyme is overexpressed in many colorectal tumors causing colorectal carcinogenesis and prevent or revert the growth increased prostaglandin (PG) levels in the tissue (6) . Conof premalignant colonic polyps. They inhibit cyclooxygenase sequently, COX-2-specific inhibitors are under development (COX) but recent data indicate that this is not the only as tumor-preventive drugs in the colon without the side effects or even the most important mechanism of inhibition in caused by systemic inhibition of both COX isoenzymes (7, 8) .
colorectal tumor cells. We have used colonic carcinoma
Available data have indicated that NSAID treatment normaland adenoma cell lines to study the effects of the NSAID izes the rate of cell death of differentiated cells in early sulindac sulfide, its COX-inactive metabolite, sulindac sulpremalignant lesions, preventing polyp formation (9,10). In fone, and the isoenzyme-specific inhibitors SC58125, SC236 addition, reversion of preexisting polyps has been observed and SC58560 on tumor cell growth in relation to COX-2 during NSAID treatment (for example see refs 4 and 11). This expression and prostaglandin production. To establish the can only be explained by induction of cell death in the role of COX-2 in NSAID action, we constructed clones premalignant cell population of the adenomatous polyps. In expressing different levels of COX-2 from SW480 cells. All contrast, in vitro studies have shown that malignant carcinoma five compounds inhibited DNA synthesis and/or induced cells are more sensitive to NSAID exposure than premalignant apoptosis, each with a characteristic pattern. ID 50 s were adenomas. This effect has also been observed in cells that do very similar in all the cell lines and were independent of not express COX-2 at all (12). COX expression, except for the COX-1 inhibitor SC58560, Recent evidence suggests that the tumor-inhibitory efficacy which was least effective in HT29/HI1, the cell line of NSAIDs and similar drugs is not necessarily related to their expressing the highest level of COX-1 (ID 50 70 µM; in COX-inhibitory potential. In a rat in vivo model, inhibition of other cells lines the ID 50 was 15 µM). For all other tumorigenesis occurred at NSAID concentrations that did not compounds ID 50 concentrations varied less than two-fold:
inhibit PG synthesis (13). Furthermore, sulindac sulfone, a 25-40, 40-90 and 150 µM for SC236, sulindac sulfide and sulindac metabolite that does not inhibit COXs, affects polyp sulindac sulfone, respectively. SC58125 was the weakest growth and tumor development (14-17). inhibitor, never causing Ͼ50% cell loss. All compounds Taken together, these data raise questions about cellular modulated expression of Bcl-2 and Bak and activated targets and the mechanism of action of NSAIDs and other caspase 3. Overexpression of COX-2 in SW480 cells pro-COX inhibitors in colorectal tumor cells. While this has been tected them against induction of apoptosis by sulindac shown in studies using one or a few tumor cell lines with sulfide. The effect was restricted to clones producing high different levels of COX-2 expression (12,16,18,19), a detailed levels of prostaglandin E 2 . In summary, our data indicate analysis of COX-2-dependent and/or -independent effects in a that both COX-dependent and COX-independent mechandefined system is still lacking. The present study aims to isms are involved in NSAID-induced growth in colorectal address such questions by investigating the growth effects of tumor cells. The concentrations necessary to inhibit growth sulindac and of specific COX-1 and COX-2 inhibitors on were higher than serum concentrations that can be obtained colorectal carcinoma and adenoma cell lines. COX-2 overexin vivo, indicating that the therapeutic effect of NSAIDs pressing clones were constructed from SW480 cells, which cannot be explained by a direct effect of NSAIDs on the initially do not produce detectable COX-2 and PG, to analyze epithelial cells alone. For therapeutic purposes, compounds the relationship between growth effects, COX-2 expression using different targets could be used to minimize side and PG production. effects while optimizing therapeutic effect. Cancer Center, Case Western University, Cleveland, OH) and were cultured 5Ј-AGATCATCTCTGCCTGAGTATCTT-3Ј; RPL6: sense, 5Ј-GGTCTAGA-AATGCCTAGGTATTA-3Ј; antisense, 5Ј-GAAGAATACGCCCAGTGAGGin MEM 2ϩ [HEPES-buffered MEM containing 2% FCS, 2 ϫ 10 -10 M triiodo-L-thyronine, 1 µg/ml hydrocortisone, 10 µg/ml insulin, 2 µg/ml transferrin, ATGA-3Ј. Amplification of the target gene and RPL6 were performed in one reaction 5 ϫ 10 -9 M selenite and 30 ng/ml epidermal growth factor (EGF); see ref. 26] . Their doubling time was~60 h. The LT97 cell line was established from from four primers using cycles of 40 s denaturation at 94°C, 50 s annealing at 55°C and 30 s extension at 72°C. To assess gene expression of the target the mucosa of a familal polyposis patient, which consisted mainly of small tubular polyps (our unpublished data; M.Richter manuscript in preparation).
Materials and methods Introduction
genes, reactions were performed for 23, 25, 27 and 29 cycles and products were separated on 8% acrylamide gels. Bands were stained with Vistra Green They were maintained in MCDB203 medium containing 20% L15 medium(Sigma), 2% FCS, 2 ϫ 10 -10 M triiodo-L-thyronine, 1 µg/ml hydrocorand visualized and quantified using a FluorImager and ImageQuant software (Molecular Dynamics). tisone (302 medium (Sigma)) supplemented with 10 µg/ml insulin, 2 µg/ml transferrin, 5 ϫ 10 -9 M selenite and 30 ng/ml EGF. Their doubling time under
Prostaglandin production these conditions was~96 h.
Cells were plated at 5 ϫ 10 4 cells/well into 24-well plates. Twenty-four hours COX inhibitors later, the cultures were exposed to treatment or control media containing SC58125, SC236 and SC58560 were a gift from Searl (Skokie, IL); sulindac 10 µM arachidonic acid to provide sufficient substrate for exactly 24 h. PGE 2 sulfide and sulindac sulfone were obtained from Biomol Research Laboratories secreted into the medium was determined by competitive ELISA using a kit (Plymouth Meeting, PA). Stock solutions were prepared in dimethylsulfoxide from Cayman Chemicals (Ann Arbor, MI) according to the manufacturer's (DMSO) and stored at -20°C. Cells were plated at 5 ϫ 10 4 cells/well in instructions. In short, medium from cells was added to 96-well plates coated 24-well plates, left to attach for 24 h (SW480, HT29/HI1), 48 h (VACO235)
with an anti-mouse antibody, mixed with a PG/acetylcholinesterase tracer and or 96 h (LT97) and then exposed to inhibitors. Inhibitors were provided in a monoclonal antibody against prostaglandin and incubated at 4°C overnight. HEPES-buffered MEM containing 1 mg/ml bovine serum albumin (BSA) for Unbound PG/acetylcholinesterase was removed and washed extensively and SW480, HT29/HI1 and VACO235 and in 203 basic medium for LT97 cells.
bound acetylcholinesterase was detected by Ellman's reagent and measured Control media contained the appropriate volume of DMSO; DMSO content at 414 nm. PG standard dilutions were prepared in MEM containing was limited to 6 µl/ml, which resulted in slight growth inhibition after 72 h.
1 mg/ml BSA and the PG content was determined from the standard curve.
Exposure to exogenous prostaglandins COX-2-overexpressing clones PGE 2 , PGF 2α or dimethyl-PGE 1 were obtained from Sigma (St Louis, MO).
SW480 cells (5 ϫ 10 6 ) were suspended in 800 µl of medium containing 10% They were kept as stock solutions in ethanol under a N 2 atmosphere at -80°C FCS, 25 µg pcDNA3 carrying the COX-2 cDNA and 5 µg PEGFP-N3 and and diluted into MEM containing 1 mg/ml BSA immediately before use.
incubated for 3 min at room temperature. Controls were incubated with equal amounts of vector DNA and PEGFP-N3. DNA was transfected using Growth parameters electroporation at 250 V and 1500 µF using an Easyjectϩ (EquiBio, Kent, Two assays were used to determine cell numbers. In most experiments cells UK) 450V twin pulse electroporator. Immediately after the pulse, cells were were incubated with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium transfered into two Petri dishes containing 10 ml of MEM supplemented with bromide (MTT). This compound is oxidized by cells with intact mitochondria 10% FCS and left to attach. DNA uptake, as judged by green fluorescent and yields a purple product that can be solubilized with DMSO. Alternatively, protein (GFP) fluorescence, was~30%. Geneticin (G418) was added to the Neutral Red uptake during a 2 h period from serum-free MEM containing medium to select transfected cells 4 days after transfection. G418-resistant 50 µg/ml Neutral Red was measured. This dye is taken up into the lysosomes clones were isolated after 2-3 weeks of selection and passaged whenever they of viable cells, from where it can be dissolved with 1% acetic acid in were confluent. 70% ethanol.
Neutral Red was washed out using first 70% ethanol and then PBS and
Results
fixed cells were then stained with 800 ng/ml Hoechst 33285. Nuclei with chromatin condensed at the nuclear margin or in the center of the nucleus as well as fragmented nuclei were classified as apoptotic. Apoptotic index was shown in Figure 1a and b: SW480 expressed low levels of Immunoblotting COX-1, but no detectable COX-2 mRNA, HT29/HI1 expressed both isoenzymes at significant levels, and VACO235 expressed Cells were washed twice with ice-cold PBS and homogenized in lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100, high levels of COX-2 but hardly any COX-1. To determine growth effects, we added the COX-2 inhibitors SC236 and SC125, the COX-1 inhibitor SC560, sulindac
Expression of COX isoenzymes and prostaglandin synthesis in

COX-1 and COX-2 expression in tumor cells
sulfide or its COX-inactive metabolite sulindac sulfone to the mRNA was isolated from subconfluent cultures using Trizol (Gibco Life Technologies, Paisley, UK) and chloroform extraction. Aliquots (50 ng) were tissue culture medium of carcinoma and adenoma cell lines.
used to prepare and amplify cDNA using the reverse transcription-polymerase
Cell numbers were measured after 72 h using the MTT assay.
chain reaction (RT-PCR) Ready-To-Go kit from Pharmacia H (Peapack NJ).
The results showed a reduction of cell numbers to varying
The following primer pairs were used: COX-1: sense, 5Ј-TGCCCAGCTCCdegrees with all compounds in all cell lines used (Figure 2 ).
TGGCCCGCTT-3Ј; antisense, 5Ј-GTGCATCAACACAGGCGCCTCTTC; COX-2: sense, 5Ј-TTCAAATGAGATTGTGGGAAAATT-3Ј; antisense,
Differences in sensitivity between cell lines were only minor when SC236 was used: ID 50 concentrations ranged between 60% of that in controls in the 25 µg/ml SC236 group ( Figure  3a) . Effects on SW480 cells were weak, just reaching 50% of 25 and 40 µM, with LT97 adenoma cells being the most sensitive by a small margin (Figure 2a) . SC125, the other control using SC125, SC560 or the sulindac metabolites. Stronger inhibition of DNA synthesis was only observed with COX-2 inhibitor, was much less effective. Only SW480 cells were affected to any significant degree (ID 50 ϭ 40 µM) while sulindac sulfide and sulfone in VACO235 adenoma cells and with SC236 in SW480 and VACO235. In LT97 adenoma cell numbers for all other cell lines did not drop below 60% of control at 80 µM, the highest concentration that did not cultures, BrdU incorporation in control cultures (302 basic medium) was extremely low and hardly affected by exposure precipitate during the incubation period (Figure 2b ). With SC560, there were major differences between cell lines, HT29/ to SC125, SC560 or sulindac sulfone. After exposure to SC236 and sulindac sulfide, BrdU incorporation was lost together HI1 (the cell line with the highest expression of COX-1) being about five-fold less sensitive than SW480 or VACO235 (15 with the reduction in cell numbers in these cultures (compare Figures 2a and d and 3a and d) . and 70 µM, respectively). LT97 adenoma cells were as insensitive as HT29/HI1 cells (Figure 2c ). With the sulindac In contrast, induction of apoptosis was a strong factor in NSAID-induced growth inhibition. Cultures were fixed after metabolites, low concentrations caused slight increases in cell number, especially with the VACO235 adenoma cells. At 24 h of exposure and stained with Hoechst 33285 dye. The incidence of apoptotic and mitotic nuclei was counted in 1000 higher concentrations, cell loss was highest in LT97. With sulindac sulfide, ID 50 was 25 µM in the LT97 cultures and cells each of duplicate cultures. The results obtained with SW480 cells are summarized in Table I : there was a dose 40-90 µM with all other cell lines (Figure 2d ). With sulindac sulfone the differences were not as pronounced; the ID 50 was dependent increase in the proportion of apoptotic nuclei in cultures with all four compounds. At the same time thẽ150 µM for all cell lines (Figure 2e) . DNA synthesis was measured in parallel cultures after 24 h incidence of mitosis decreased, approaching zero. Results obtained using the other cell lines were qualitatively similar to assess whether a reduction of cell production contributed to the overall growth inhibition. It was also decreased but to (not shown).
To obtain further proof for the induction of apoptosis, we a lesser degree than cell number; there were clear differences between cell lines (Figure 3 ): HT29/HI1 cells were hardly lysed SW480 cells after short-term exposure to SC236, SC560 or the sulindac metabolites. SC125 was not included because affected, with the lowest rate of BrdU incorporation being 5 . PGE 2 production during exposure to inhibitors. Cells were plated and exposed to inhibitors as for the growth experiments (Figures 2 and 3) except that exactly 0.5 ml of medium was used per well and media were collected after exactly 24 h. PGE 2 content of the conditioned media was determined by ELISA. Results are mean Ϯ SD of triplicate assays and two experiments.
in this regard: a drop in Bcl-2 was evident at 8 h followed by a recovery later, Bak levels remained constant and pro-caspase was reduced from 8 h onwards, indicating proteolytic activation of the enzyme, but the effect was less than that with SC560. The latter compound was the most active in this analysis, Both sulindac compounds caused a slow decrease in Bcl-2 sequentially from the same blots using monoclonal antibodies. and pro-caspase, which only became obvious after 24 and 48 h, while Bak levels remained constant.
PG production under growth-inhibitory conditions was deter- VACO235 cells, with their 40-fold higher baseline production, inhibition was less but still significant ( Figure 5 ). with different levels of COX-2 expression and PGE 2 production microscopy and incidence of apoptosis counted from 1000 cells per well in duplicate (mean Ϯ SD).
( Figure 6 ) and five clones transfected with the control plasmid. COX-2 clones showed a large spectrum of growth alterations, mainly consisting of growth retardation and increased serum its growth effects were only minor. Lysates were analyzed by western blotting using antibodies against Bcl-2, Bak and prodependency. None of these effects was related to the level of COX expression (Table II) . caspase 3 (Figure 4) . Surprisingly, SC236 had the least effect a of Bcl-2 expression in overexpressing clones, but also in three of five control clones (not shown). This increase was observed regardless of whether the cells were protected from apoptosis or not and exposure to inhibitor compounds still reduced the amount of Bcl-2 ( Figure 8) .
Discussion
All the compounds tested-the NSAID sulindac sulfide, its metabolite sulindac sulfone, the specific COX-2 inhibitors b SC125 and SC236 and the COX-1 inhibitor SC560-inhibited growth of colorectal tumor cells. Both induction of apoptosis and inhibition of proliferation (DNA synthesis) were part of the overall effect of all five compounds, but each had its characteristic pattern of effects. The effects were independent of the activity and specificity of the compound towards COX isoenzymes. Even the COX-inactive metabolite sulindac sulfone had qualitatively the same effect, although higher concentrations were necessary (the ID 50 Inhibition of DNA synthesis must play only a minor role in growth inhibition by the tested compounds, as DNA synthesis by the two carcinoma cell lines never dropped below 50% of that in controls. Only the VACO235 adenoma cells displayed strong inhibition of proliferation (DNA synthesis). Induction of apoptosis was stronger, as shown by the increase in the proportion of apoptotic cells in the treated cultures. Apoptosisrelated proteins were only analyzed in SW480 cells, where loss of Bcl-2, induction of Bak and activation of caspase 3 occurred, again in different individual patterns for the indi- slight activation of caspase at 48 h. In this case, induction and execution of apoptosis are probably caused by another mechanism, which is currently under investigation. To determine the effect of COX-2 expression on the sensitivity towards COX inhibitors, we repeated the experiment shown Overexpression of COX-2 in SW480-protected cells from apoptosis induced by sulindac sulfide, but not that induced by in Figure 2 with a panel of clones displaying different levels of COX-2 expression and PGE 2 production. We constructed the sulfone metabolite. The protective effect was restricted to the two clones with the highest PG production, indicating that dose-response curves for all compounds, comparing overexpressors with control clones. Figure 7 summarizes data from at least part of the effect of NSAIDs on cell growth is mediated by COX-2 inhibition and decreased PG levels, as postulated three independent experiments that protected against sulindac sulfide in clones 2 and 32, which produce high amounts of previously (25) . Another component of the overall effect might well be shared with sulindac sulfone, which induced apoptosis PGE 2 (Figure 7d) . Protection against the COX-2 inhibitor SC125 was observed in clone 32 (Figure 7b ), but there was at three to five times higher concentrations than the sulfide. With the COX-2 inhibitor SC125, protection was observed in no protection against other inhibitor compounds, including the COX-2 inhibitor SC236. Low and intermediate expressors the COX32 clone, which produces high levels of PG. SC236 effects, on the other hand, were not affected by were at least as sensitive as controls towards all compounds.
Analysis of apoptosis-associated proteins showed an increase increased COX-2 expression and PG levels or by exogenous Figure 6 ). Measurements for VACO235 were done in an earlier experiment using RPL6 as the housekeeping gene (Figure 1b ). c Mean Ϯ SD of triplicates. d Cells were plated at 2.5 ϫ 10 4 cells/well in 24-well plates and cell number determined on days 1, 3, 5, 7 and 9. Doubling times were assessed during the logarithmic growth phase. e Cells were plated at 5 ϫ 10 4 cells/well and changed to serum-free MEM or MEM containing 10% FCS 24 h later. Cell numbers were determined 72 h after the change in medium and the quotient of cell number in serum-free MEM and cell number in FCS is given. Fig. 7 . Induction of apoptosis in COX-2-overexpressing clones. Cells were plated as in Figure 2 and exposed to inhibitors for 72 h. Cell number was determined using the MTT assay. The results are given as a percentage of control values and are the mean Ϯ SEM from three or more experiments each using triplicate assays.
PG substitution. Therefore, we have to assume that even other mechanisms: while ജ50% of cells were lost within 24 h of SC236 exposure and the fraction of apoptotic cells in the though the drug is a highly effective COX-2 inhibitor and was the most potent growth inhibitor used in this study, these two population increased, as seen with other drugs, those markers of apoptosis that were modulated by sulindac and even more attributes are independent of one another. Analysis of apoptosisrelated proteins also supports the assumption that SC236 uses strongly by SC560 were barely affected by SC236. This clearly egies. Compounds with different mechanisms of action should also display different side effects and a combination of such compounds could be used to minimize side effects while maximizing the therapeutic outcome.
